U.S. market Closed. Opens in 1 day 1 hour 17 minutes

NEXI | NexImmune, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of Revenue1.02M1.50M870.28K618.99K436.37KN/A
Gross Profit-1.02M-1.50M-870.28K-618.99K-436.37KN/A
Operating Expenses28.17M63.08M53.26M27.85M20.89M13.24M
Selling, General & Admin9.91M15.93M15.80M10.01M5.71M5.24M
Research & Development18.26M47.15M37.46M17.84M15.17M8.00M
Other Operating Expenses690.77M-87.68K-61.41K89.78K92.28K136.79K
Operating Income-29.19M-63.08M-53.26M-27.85M-20.89M-13.24M
Other Expenses / Income-3.15M576.69K2.35M-2.01M339.06K136.79K
Before Tax Income-32.34M-62.51M-50.90M-29.87M-20.55M-12.83M
Income Tax Expenses-2.00-576.69M843.92K1.77M-246.78K409.22K
Net Income-32.34M514.18M-51.75M-31.64M-20.30M-12.83M
Interest ExpensesN/A-576.69M905.33K1.68MN/AN/A
Basic Shares Outstanding1.05M962.36K913.16K910.31K900.86K9.77M
Diluted Shares Outstanding1.05M962.36K913.16K910.31K900.86K9.77M
EBITDA-28.17M-62.51M-52.39M-27.12M-20.45M-13.04M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-32.34M-639.20M-50.00M-28.18M-20.55M-12.42M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙